LINC00346 Sponges MiR-30c-2-3p to Promote the Development of Lung Adenocarcinoma by Targeting MYBL2 and Regulating CELL CYCLE Signaling Pathway

Overview

Journal Front Oncol

Specialty Oncology

Date 2021 Oct 11

PMID 34631522

Citations 10

Authors

Qian Xu

Zhenwu Xu

Kai Zhu

Jinlan Lin

Bo Ye

Affiliations

Soon will be listed here.

Abstract

Background: LINC00346 has recently been reported to regulate the development of several cancer types, but its biological functions and underlying mechanisms in lung adenocarcinoma (LUAD) have not been elucidated. The purpose of this study was to investigate the molecular mechanism of LINC00346 in the progression of LUAD.

Methods: Bioinformatics was performed to find the target lncRNA, miRNA and mRNA, and the binding relationship between the target genes was verified by dual luciferase reporter gene and RIP assays. Fluorescence hybridization was used to detect the location of LINC00346 in LUAD tissues. The expressions of LINC00346, miR-30c-2-3p and MYBL2 in each group were detected by qRT-PCR, and western blot was performed to detect expressions of MYBL2 and CELL CYCLE related proteins. Proliferation, metastasis, apoptosis and cell cycle of LUAD cells were detected by CCK-8, colony formation, Transwell and flow cytometry assays, respectively. Mouse xenograft models were established to further determine the effects of LINC00346 on LUAD tumor growth .

Results: LINC00346 was upregulated in LUAD tissues and cells and was mainly localized in the cytoplasm. Knockdown of LINC00346 inhibited tumor growth , proliferation, metastasis and cell cycle progression, while induced apoptosis. LINC00346 sponged miR-30c-2-3 by targeting MYBL2 and regulating CELL CYCLE signaling pathway. Inhibiting miR-30c-2-3p or overexpressing MYBL2 could reverse the inhibitory effect of LINC00346 knockdown on LUAD process.

Conclusions: LINC00346 as a ceRNA played a carcinogenic role in the development of LUAD miR-30c-2-3p/MYBL2 axis regulating the CELL CYCLE signaling pathway. The study generally elucidated the mechanism by which LINC00346 regulated the development of LUAD, providing new ideas for the diagnosis and treatment of LUAD guided by lncRNA.

Citing Articles

Comprehensive insights and In silico analysis into the emerging role of LincRNAs in lung diseases pathogenesis; a step toward ncRNA precision.

Hamdy N, Zaki M, Abdelmaksoud N, Elshaer S, Abd-Elmawla M, Rizk N Funct Integr Genomics. 2025; 25(1):34.

PMID: 39912974 PMC: 11802690. DOI: 10.1007/s10142-025-01540-1.

MicroRNA‑mediated regulation in lung adenocarcinoma: Signaling pathways and potential therapeutic implications (Review).

Liu J, Zhang F, Wang J, Wang Y Oncol Rep. 2023; 50(6).

PMID: 37859595 PMC: 10603552. DOI: 10.3892/or.2023.8648.

Oncogenic Targets Regulated by Tumor-Suppressive and : Facilitates Cancer Cell Aggressiveness in Breast Cancer.

Mitsueda R, Toda H, Shinden Y, Fukuda K, Yasudome R, Kato M Cancers (Basel). 2023; 15(16).

PMID: 37627217 PMC: 10453418. DOI: 10.3390/cancers15164189.

Gene Expression in Synovium of Rotator Cuff Tear Patients Determined by RNA Sequencing.

Qian H, Meng J, Yuan T, Jiang H, Zhou L, Zhang L Biochem Genet. 2023; 62(1):452-467.

PMID: 37380850 DOI: 10.1007/s10528-023-10411-y.

The effects of the prognostic biomarker SAAL1 on cancer growth and its association with the immune microenvironment in lung adenocarcinoma.

Tong S, Jiang N, Wan J, Chen C, Wang S, Wu C BMC Cancer. 2023; 23(1):275.

PMID: 36973678 PMC: 10041717. DOI: 10.1186/s12885-023-10741-5.

References

Das E, Jana N, Bhattacharyya N . MicroRNA-124 targets CCNA2 and regulates cell cycle in STHdh(Q111)/Hdh(Q111) cells. Biochem Biophys Res Commun. 2013; 437(2):217-24. DOI: 10.1016/j.bbrc.2013.06.041. View

Li W, Zhang B, Jia Y, Shi H, Wang H, Guo Q . LncRNA LOXL1-AS1 regulates the tumorigenesis and development of lung adenocarcinoma through sponging miR-423-5p and targeting MYBL2. Cancer Med. 2019; 9(2):689-699. PMC: 6970024. DOI: 10.1002/cam4.2641. View

Peng W, He R, Zhang Z, Yang L, Mo Y . LINC00346 promotes pancreatic cancer progression through the CTCF-mediated Myc transcription. Oncogene. 2019; 38(41):6770-6780. DOI: 10.1038/s41388-019-0918-z. View

Yu R, Li C, Lin X, Chen Q, Li J, Song L . Clinicopathologic features and prognostic implications of MYBL2 protein expression in pancreatic ductal adenocarcinoma. Pathol Res Pract. 2017; 213(8):964-968. DOI: 10.1016/j.prp.2017.04.024. View

Tang C, Liang Q, Yang L, Lin X, Wu S, Chen Y . RAB31 Targeted by MiR-30c-2-3p Regulates the GLI1 Signaling Pathway, Affecting Gastric Cancer Cell Proliferation and Apoptosis. Front Oncol. 2018; 8:554. PMC: 6275292. DOI: 10.3389/fonc.2018.00554. View

Shukla K, Sharma A, Ward A, Will R, Hielscher T, Balwierz A . MicroRNA-30c-2-3p negatively regulates NF-κB signaling and cell cycle progression through downregulation of TRADD and CCNE1 in breast cancer. Mol Oncol. 2015; 9(6):1106-19. PMC: 5528752. DOI: 10.1016/j.molonc.2015.01.008. View

Yu N, Yong S, Kim H, Choi Y, Jung Y, Kim D . Identification of tumor suppressor miRNAs by integrative miRNA and mRNA sequencing of matched tumor-normal samples in lung adenocarcinoma. Mol Oncol. 2019; 13(6):1356-1368. PMC: 6547618. DOI: 10.1002/1878-0261.12478. View

Terashima M, Ishimura A, Wanna-Udom S, Suzuki T . long noncoding RNA contributes to epigenetic progression of the epithelial-mesenchymal transition of lung and pancreatic cancer cells. J Biol Chem. 2018; 293(47):18016-18030. PMC: 6254362. DOI: 10.1074/jbc.RA118.004006. View

Zhan Y, Chen Z, Li Y, He A, He S, Gong Y . Long non-coding RNA DANCR promotes malignant phenotypes of bladder cancer cells by modulating the miR-149/MSI2 axis as a ceRNA. J Exp Clin Cancer Res. 2018; 37(1):273. PMC: 6233575. DOI: 10.1186/s13046-018-0921-1. View

10.

Liu Y, Wang J, Dong L, Xia L, Zhu H, Li Z . Long Noncoding RNA HCP5 Regulates Pancreatic Cancer Gemcitabine (GEM) Resistance By Sponging Hsa-miR-214-3p To Target HDGF. Onco Targets Ther. 2019; 12:8207-8216. PMC: 6781945. DOI: 10.2147/OTT.S222703. View

11.

Chen R, Xia W, Wang S, Xu Y, Ma Z, Xu W . Long Noncoding RNA SBF2-AS1 Is Critical for Tumorigenesis of Early-Stage Lung Adenocarcinoma. Mol Ther Nucleic Acids. 2019; 16:543-553. PMC: 6506611. DOI: 10.1016/j.omtn.2019.04.004. View

12.

Zhao X, Li X, Zhou L, Ni J, Yan W, Ma R . LncRNA HOXA11-AS drives cisplatin resistance of human LUAD cells via modulating miR-454-3p/Stat3. Cancer Sci. 2018; 109(10):3068-3079. PMC: 6172072. DOI: 10.1111/cas.13764. View

13.

Ge X, Li G, Jiang L, Jia L, Zhang Z, Li X . Long noncoding RNA CAR10 promotes lung adenocarcinoma metastasis via miR-203/30/SNAI axis. Oncogene. 2019; 38(16):3061-3076. PMC: 6484688. DOI: 10.1038/s41388-018-0645-x. View

14.

Calvayrac O, Pradines A, Pons E, Mazieres J, Guibert N . Molecular biomarkers for lung adenocarcinoma. Eur Respir J. 2017; 49(4). DOI: 10.1183/13993003.01734-2016. View

15.

Ye T, Ding W, Wang N, Huang H, Pan Y, Wei A . Long noncoding RNA linc00346 promotes the malignant phenotypes of bladder cancer. Biochem Biophys Res Commun. 2017; 491(1):79-84. DOI: 10.1016/j.bbrc.2017.07.045. View

16.

Qin H, Li Y, Zhang H, Wang F, He H, Bai X . Prognostic implications and oncogenic roles of MYBL2 protein expression in esophageal squamous-cell carcinoma. Onco Targets Ther. 2019; 12:1917-1927. PMC: 6415733. DOI: 10.2147/OTT.S190145. View

17.

Yin Y, Zheng W, Zhang X, Chen Y, Tuo Y . LINC00346 promotes hepatocellular carcinoma progression via activating the JAK-STAT3 signaling pathway. J Cell Biochem. 2019; 121(1):735-742. DOI: 10.1002/jcb.29319. View

18.

Fan J, Zhang X, Wang S, Chen W, Li Y, Zeng X . Regulating autophagy facilitated therapeutic efficacy of the sonic Hedgehog pathway inhibition on lung adenocarcinoma through GLI2 suppression and ROS production. Cell Death Dis. 2019; 10(9):626. PMC: 6700102. DOI: 10.1038/s41419-019-1840-6. View

19.

Zhang L, Huang P, Li Q, Wang D, Xu C . miR-134-5p Promotes Stage I Lung Adenocarcinoma Metastasis and Chemoresistance by Targeting DAB2. Mol Ther Nucleic Acids. 2019; 18:627-637. PMC: 6838973. DOI: 10.1016/j.omtn.2019.09.025. View

20.

Siegel R, Miller K, Jemal A . Cancer statistics, 2019. CA Cancer J Clin. 2019; 69(1):7-34. DOI: 10.3322/caac.21551. View